Grow smarter, harvest bigger We make bioproduction Higher Read More Grow smarter, harvest bigger We make bioproduction cheaper Read More Grow smarter, harvest bigger We make bioproduction cleaner Contact

Animal-Free 3D Cell Culture

We Make Biomanufacturing Simpler & Cheaper

Up to 200× more cells in the flasks you already use. Same incubator, same medium, 100% animal-free.

CellSpace HA ready-to-use formats: flask, Erlenmeyer, Petri dish and plate

CellSpace HA™ ready-to-use formats: flask, Erlenmeyer, Petri dish and plate

The Foundation Of Our Platform

CellSpace HA™

Designer-6_logo1916

One Platform, Many Markets

Where CellSpace HA™ Creates Value

Every biologic starts with growing cells. We give producers more output from the same cells, in the labware they already use, from research to scale-up.

$650B+cell-based production market by 2034
$104Bserviceable market we address
4validated application areas

Biologics Production

Antibody market: $200B+

The challenge

Cost pressure, limited yields and scale-up bottlenecks.

What OctoCells provides

  • ≥12× antibody yield vs 2D
  • Up to 200× cell density, −83% medium
  • 100% animal-free matrix

Cell & Gene Therapy

Viral vector & plasmid manufacturing: $22B by 2032

The challenge

Producer cells die within days, forcing costly repeated transfections.

What OctoCells provides

  • Production extended to day 10
  • From 2 to 9 harvests per transfection
  • Functional CAR-T from raw supernatant

Research & Preclinical Models

3D cell culture: $4B by 2033

The challenge

Need for predictive, reproducible and long-lasting 3D models.

What OctoCells provides

  • Active culture beyond 60 days
  • Imaging directly in the vessel
  • Custom stiffness on request

Cosmetics & Bioactive Ingredients

Cosmetic active ingredients: $4B+

The challenge

Demand for animal-free, traceable and sustainable actives.

What OctoCells provides

  • Animal-free HA matrix and beads
  • Cell-derived actives and EVs
  • Same platform, from lab to production

Market figures: OctoCells estimates and industry reports (SNS Insider 2025, DataM Intelligence, Personal Care Magazine).

Our Vision

From Flask to Factory

CellSpace HA™ is the entry point. Every culture it runs generates data, and that data builds the path to smarter, cheaper and more sustainable biomanufacturing.

01 Available now

CellSpace HA™ Matrix

An animal-free 3D matrix that fits in the flasks labs already use. Up to 200× cell density, less medium, less plastic.

➜
02 In development

Digital Twin

Culture data feeds a digital twin that predicts the best conditions before scale-up. Fewer trials, faster decisions, lower costs.

➜
03 Our goal

Biomanufacturing

Manufacturing biomolecules and cell-derived actives with less space, less waste and less plastic, from lab to industrial scale.

They Support Us

Our Partners

Backed by leading academic, public and innovation partners in Normandy and across France.

The Team

Founders and Board

Scientists, engineers and entrepreneurs with one goal: making biomanufacturing simpler, cheaper and more sustainable.

Zied Souguir PhD

25 years in biomaterials and biotech innovation - Co-founder and CEO

Grégory Maubon PhD

25 years in innovation, digital, XR and AI domains - Co-founder and CTO

Aude Planche

Partner in a $3.4 billion investment group with a strong track record as a seasoned investor - Investor and advisor

Nicolas Labarbarie

Dental Surgeon - Investor and advisor

Mehdi Chelbi

Entrepreneur in Biotech and Healthcare with nearly 20 years of experience in Drug Discovery - Investor and advisor

Benoit Seyeux

Serial Entrepreneur - Investor and advisor

Our Blog

Featured Articles

Grow More With Less

Test CellSpace HA™ in your own lab, or talk to us about building the future of biomanufacturing together.